New non-exec at Barclays buys again
A round-up of the biggest director deals today so far.
Reuben Jeffery III, a non-executive director of UK banking giant Barclays, dipped into his pocket to buy 6,000 American Depositary Shares (ADS) at an average price of $22.8398 per ADS. Each ADS represent four ordinary shares in Barclays.
The total cost of the purchase to Jeffery was £82,762 and brings his holding up to 6,500 ADS and 173 ordinary shares in Barclays.
Jeffery is a senior adviser at the Center for Strategic & International Studies in Washington DC, and has previously served as Under Secretary of State for Economic, Energy and Agricultural Affairs in the final two years of the presidency of George W. Bush.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
He joined Barclays as a non-executive director in July and was formerly a managing partner of Goldman Sachs in Paris.
Top Director Buys
Value: £82,762
Value: £35,750
Value: £29,494
Value: £16,176
Value: £10,061
Top Director Sells
Value: £2,746,218
Value: £2,683,408
Value: £1,174,877
Value: $697,425
Value: $609,785
Value: $541,650
Value: £411,000
Value: $408,139
Value: £405,700
Value: $366,293
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
UK-US trade deal announced: US cuts tariffs on UK car imports to 10%
Keir Starmer and Donald Trump have announced a UK-US trade deal, but the US president has refused to lift baseline tariffs on most UK goods. What does it mean for the UK?
-
How to use mid-caps to diversify from the US
Medium sized companies are overlooked by investors but could offer an attractive ‘sweet spot’. We consider the case for mid-caps amid market volatility.